GP-Act III Acquisition (GPAT) Competitors $10.14 -0.01 (-0.10%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends GPAT vs. AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, AITRR, AFJKR, and AIMBUShould you be buying GP-Act III Acquisition stock or one of its competitors? The main competitors of GP-Act III Acquisition include AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), AI Transportation Acquisition (AITRR), Aimei Health Technology (AFJKR), and Aimfinity Investment Corp. I (AIMBU). These companies are all part of the "trading" industry. GP-Act III Acquisition vs. AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Aimei Health Technology Aimfinity Investment Corp. I AGBA Group (NASDAQ:AGBAW) and GP-Act III Acquisition (NASDAQ:GPAT) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends. Is AGBAW or GPAT more profitable? Company Net Margins Return on Equity Return on Assets AGBA GroupN/A N/A N/A GP-Act III Acquisition N/A N/A N/A Does the MarketBeat Community believe in AGBAW or GPAT? AGBA Group and GP-Act III Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAGBA GroupN/AN/AGP-Act III AcquisitionN/AN/A Which has stronger earnings & valuation, AGBAW or GPAT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAGBA Group$38.55MN/AN/AN/AN/AGP-Act III AcquisitionN/AN/AN/AN/AN/A Does the media favor AGBAW or GPAT? In the previous week, AGBA Group's average media sentiment score of 0.00 equaled GP-Act III Acquisition'saverage media sentiment score. Company Overall Sentiment AGBA Group Neutral GP-Act III Acquisition Neutral SummaryAGBA Group beats GP-Act III Acquisition on 1 of the 1 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get GP-Act III Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GPAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GPAT vs. The Competition Export to ExcelMetricGP-Act III AcquisitionInvestment Offices IndustryFinance, Insurance, And Real Estate SectorNASDAQ ExchangeMarket CapN/A$1.02M$9.37B$9.08BDividend YieldN/AN/A0.99%4.23%P/E RatioN/AN/A3.2817.20Price / SalesN/AN/A2.93117.04Price / CashN/AN/AN/A37.85Price / BookN/A2.132.134.78Net IncomeN/A-$57.64M-$57.64M$225.60M7 Day PerformanceN/A0.11%-0.98%-1.23%1 Month Performance0.55%-1.13%-1.95%0.46%1 Year PerformanceN/A-0.86%6.57%15.24% GP-Act III Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GPATGP-Act III AcquisitionN/A$10.14-0.1%N/AN/A$0.00N/A0.00N/AAGBAWAGBA GroupN/A$0.20-6.8%N/A+1,016.4%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.89+0.8%N/A+12.0%$0.00$1.26B0.0050AGNCOAGNC InvestmentN/A$25.47flatN/A+8.0%$0.00$1.26B0.0050AGNCNAGNC InvestmentN/A$25.68+0.2%N/A+1.0%$0.00$1.26B0.0050News CoverageAGNCMAGNC InvestmentN/A$25.32-0.3%N/A+5.6%$0.00$1.26B0.0050AGNCLAGNC InvestmentN/A$25.30+0.7%N/A+14.7%$0.00$1.26B0.0050ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.29-2.5%N/AN/A$0.00N/A0.00N/APositive NewsGap DownAITRRAI Transportation AcquisitionN/A$0.16+9.1%N/AN/A$0.00N/A0.00N/APositive NewsAFJKRAimei Health TechnologyN/A$0.18flatN/AN/A$0.00N/A0.00N/APositive NewsAIMBUAimfinity Investment Corp. IN/A$11.76flatN/A+7.5%$0.00N/A0.002Positive News Related Companies and Tools Related Companies AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors Aimei Health Technology Competitors Aimfinity Investment Corp. I Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GPAT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GP-Act III Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GP-Act III Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
